These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 22475066)
21. The antioxidant, MnTE-2-PyP, prevents side-effects incurred by prostate cancer irradiation. Oberley-Deegan RE; Steffan JJ; Rove KO; Pate KM; Weaver MW; Spasojevic I; Frederick B; Raben D; Meacham RB; Crapo JD; Koul HK PLoS One; 2012; 7(9):e44178. PubMed ID: 22984473 [TBL] [Abstract][Full Text] [Related]
22. Manganese porphyrin, MnTE-2-PyP, treatment protects the prostate from radiation-induced fibrosis (RIF) by activating the NRF2 signaling pathway and enhancing SOD2 and sirtuin activity. Shrishrimal S; Chatterjee A; Kosmacek EA; Davis PJ; McDonald JT; Oberley-Deegan RE Free Radic Biol Med; 2020 May; 152():255-270. PubMed ID: 32222469 [TBL] [Abstract][Full Text] [Related]
23. Methoxy-derivatization of alkyl chains increases the in vivo efficacy of cationic Mn porphyrins. Synthesis, characterization, SOD-like activity, and SOD-deficient E. coli study of meta Mn(III) N-methoxyalkylpyridylporphyrins. Tovmasyan AG; Rajic Z; Spasojevic I; Reboucas JS; Chen X; Salvemini D; Sheng H; Warner DS; Benov L; Batinic-Haberle I Dalton Trans; 2011 Apr; 40(16):4111-21. PubMed ID: 21384047 [TBL] [Abstract][Full Text] [Related]
24. Radioprotection of the brain white matter by Mn(III) n-Butoxyethylpyridylporphyrin-based superoxide dismutase mimic MnTnBuOE-2-PyP5+. Weitzel DH; Tovmasyan A; Ashcraft KA; Rajic Z; Weitner T; Liu C; Li W; Buckley AF; Prasad MR; Young KH; Rodriguiz RM; Wetsel WC; Peters KB; Spasojevic I; Herndon JE; Batinic-Haberle I; Dewhirst MW Mol Cancer Ther; 2015 Jan; 14(1):70-9. PubMed ID: 25319393 [TBL] [Abstract][Full Text] [Related]
25. Proteomic analysis of radiation-induced changes in rat lung: Modulation by the superoxide dismutase mimetic MnTE-2-PyP(5+). Yakovlev VA; Rabender CS; Sankala H; Gauter-Fleckenstein B; Fleckenstein K; Batinic-Haberle I; Jackson I; Vujaskovic Z; Anscher MS; Mikkelsen RB; Graves PR Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):547-54. PubMed ID: 20584581 [TBL] [Abstract][Full Text] [Related]
26. Manganese(III) tetrakis(1-methyl-4-pyridyl) porphyrin, a superoxide dismutase mimetic, reduces disease severity in in vitro and in vivo models for dry-eye disease. Žiniauskaitė A; Ragauskas S; Ghosh AK; Thapa R; Roessler AE; Koulen P; Kalesnykas G; Hakkarainen JJ; Kaja S Ocul Surf; 2019 Apr; 17(2):257-264. PubMed ID: 30807830 [TBL] [Abstract][Full Text] [Related]
27. Manganese-porphyrin reactions with lipids and lipoproteins. Bloodsworth A; O'Donnell VB; Batinic-Haberle I; Chumley PH; Hurt JB; Day BJ; Crow JP; Freeman BA Free Radic Biol Med; 2000 Apr; 28(7):1017-29. PubMed ID: 10832063 [TBL] [Abstract][Full Text] [Related]
28. MnTE-2-PyP, a manganese porphyrin, reduces cytotoxicity caused by irradiation in a diabetic environment through the induction of endogenous antioxidant defenses. Chatterjee A; Kosmacek EA; Shrishrimal S; McDonald JT; Oberley-Deegan RE Redox Biol; 2020 Jul; 34():101542. PubMed ID: 32361681 [TBL] [Abstract][Full Text] [Related]
29. Manganese (III) meso-tetrakis N-ethylpyridinium-2-yl porphyrin acts as a pro-oxidant to inhibit electron transport chain proteins, modulate bioenergetics, and enhance the response to chemotherapy in lymphoma cells. Jaramillo MC; Briehl MM; Batinic-Haberle I; Tome ME Free Radic Biol Med; 2015 Jun; 83():89-100. PubMed ID: 25725417 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of the potent redox-modulating manganese porphyrin, MnTE-2-PyP(5+), in plasma and major organs of B6C3F1 mice. Spasojević I; Chen Y; Noel TJ; Fan P; Zhang L; Rebouças JS; St Clair DK; Batinić-Haberle I Free Radic Biol Med; 2008 Oct; 45(7):943-9. PubMed ID: 18598757 [TBL] [Abstract][Full Text] [Related]
32. CNS bioavailability and radiation protection of normal hippocampal neurogenesis by a lipophilic Mn porphyrin-based superoxide dismutase mimic, MnTnBuOE-2-PyP Leu D; Spasojevic I; Nguyen H; Deng B; Tovmasyan A; Weitner T; Sampaio RS; Batinic-Haberle I; Huang TT Redox Biol; 2017 Aug; 12():864-871. PubMed ID: 28454069 [TBL] [Abstract][Full Text] [Related]
33. Pure MnTBAP selectively scavenges peroxynitrite over superoxide: comparison of pure and commercial MnTBAP samples to MnTE-2-PyP in two models of oxidative stress injury, an SOD-specific Escherichia coli model and carrageenan-induced pleurisy. Batinić-Haberle I; Cuzzocrea S; Rebouças JS; Ferrer-Sueta G; Mazzon E; Di Paola R; Radi R; Spasojević I; Benov L; Salvemini D Free Radic Biol Med; 2009 Jan; 46(2):192-201. PubMed ID: 19007878 [TBL] [Abstract][Full Text] [Related]
34. The metalloporphyrin antioxidant, MnTE-2-PyP, inhibits Th2 cell immune responses in an asthma model. Jungsuwadee P; Weaver MR; Gally F; Oberley-Deegan RE Int J Mol Sci; 2012; 13(8):9785-9797. PubMed ID: 22949830 [TBL] [Abstract][Full Text] [Related]
35. Lipophilicity is a critical parameter that dominates the efficacy of metalloporphyrins in blocking the development of morphine antinociceptive tolerance through peroxynitrite-mediated pathways. Batinić-Haberle I; Ndengele MM; Cuzzocrea S; Rebouças JS; Spasojević I; Salvemini D Free Radic Biol Med; 2009 Jan; 46(2):212-9. PubMed ID: 18983908 [TBL] [Abstract][Full Text] [Related]
36. Mitochondrial oxidative stress-induced apoptosis and radioprotection in proton-irradiated rat retina. Mao XW; Crapo JD; Gridley DS Radiat Res; 2012 Sep; 178(3):118-25. PubMed ID: 22780102 [TBL] [Abstract][Full Text] [Related]
37. Comprehensive pharmacokinetic studies and oral bioavailability of two Mn porphyrin-based SOD mimics, MnTE-2-PyP5+ and MnTnHex-2-PyP5+. Weitner T; Kos I; Sheng H; Tovmasyan A; Reboucas JS; Fan P; Warner DS; Vujaskovic Z; Batinic-Haberle I; Spasojevic I Free Radic Biol Med; 2013 May; 58():73-80. PubMed ID: 23328731 [TBL] [Abstract][Full Text] [Related]
38. Protection from lethal and sub-lethal whole body exposures of mice to γ-radiation by Acorus calamus L.: studies on tissue antioxidant status and cellular DNA damage. Sandeep D; Nair CK Exp Toxicol Pathol; 2012 Jan; 64(1-2):57-64. PubMed ID: 20605086 [TBL] [Abstract][Full Text] [Related]
39. Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumors. Keir ST; Dewhirst MW; Kirkpatrick JP; Bigner DD; Batinic-Haberle I Anticancer Agents Med Chem; 2011 Feb; 11(2):202-12. PubMed ID: 21291403 [TBL] [Abstract][Full Text] [Related]
40. MnTE-2-PyP modulates thiol oxidation in a hydrogen peroxide-mediated manner in a human prostate cancer cell. Tong Q; Zhu Y; Galaske JW; Kosmacek EA; Chatterjee A; Dickinson BC; Oberley-Deegan RE Free Radic Biol Med; 2016 Dec; 101():32-43. PubMed ID: 27671770 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]